AusPAR: Bevacizumab
Australian Public Assessment Report
Device/Product Name
Avastin
Active ingredients
Bevacizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2013-00709-1-4
Submission Type
Major variation (extension of indications)
Decision
Rejected